GO
Loading...

Pfizer Inc

More

  • Asian stocks tumble after weak US corporate earnings Tuesday, 27 Jan 2015 | 4:11 AM ET

    The companies that rattled the market included Microsoft, Caterpillar and Procter& Gamble. It was the biggest one-day decline for the blue-chip index since Jan. 5. "That theme,' Boy, this is the year earnings are going to come back,' suffered a little bit of a setback," said Sean Lynch, co-head of global equity strategy at Wells Fargo Investment Institute.

  • Final Glance: Pharmaceuticals companies Monday, 26 Jan 2015 | 6:04 PM ET

    Baxter International Inc. fell$. 55 or. 8 percent, to $70.88. Bristol-Myers Squibb Co. rose$. 39 or. 6 percent, to $62.46. Hospira rose $1.11 or 1.7 percent, to $66.50.

  • LONDON, Jan 26- Pfizer is to cut the price of its pneumococcal vaccine Prevenar 13 by 6 percent to $3.10 per dose in poor countries as part of a commitment to the GAVI global vaccines alliance, the U.S. drugmaker said on Monday. Pfizer's move comes as GAVI holds a major funding conference in Berlin at which it hopes to raise $7.5 billion from donors to pay for increased...

  • Most active New York Stock Exchange-traded stocks Monday, 26 Jan 2015 | 1:53 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 6 percent to $33.18 with 26,768,400 shares traded. Bank of America Corp. rose. 8 percent to $15.85 with 54,023,700 shares traded.

  • Midday Glance: Pharmaceuticals companies Monday, 26 Jan 2015 | 1:53 PM ET

    Baxter International Inc. fell$. 59 or. 8 percent, to $70.84. Bristol-Myers Squibb Co. rose$. 45 or. 7 percent, to $62.52. Hospira rose$. 42 or. 6 percent, to $65.81.

  • Early Glance: Pharmaceuticals companies Monday, 26 Jan 2015 | 12:16 PM ET

    Baxter International Inc. fell$. 58 or. 8 percent, to $70.85. Bristol-Myers Squibb Co. rose$. 06 or. 1 percent, to $62.13. Hospira fell$. 81 or 1.2 percent, to $64.58.

  • NEW YORK, Jan 26- A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells are proving to be immensely effective weapons against tumors, potentially transforming the $100 billion global market for drugs that fight the disease. But top oncology researchers are concerned about the two emerging technologies, citing...

  • Final Glance: Pharmaceuticals companies Friday, 23 Jan 2015 | 6:04 PM ET

    Baxter International Inc. fell$. 83 or 1.1 percent, to $71.43. Bristol-Myers Squibb Co. fell$. 02 or percent, to $62.07. Hospira rose$. 65 or 1.0 percent, to $65.39.

  • FDA approves 2nd vaccine against meningitis strain Friday, 23 Jan 2015 | 5:07 PM ET

    WASHINGTON— Federal health regulators have approved a second vaccine to prevent a strain of bacteria that can cause deadly cases of meningitis. The Food and Drug Administration said it cleared Novartis' Bexsero vaccine against a subtype of meningococcal bacteria in people ages 10 to 25. The agency cleared a similar vaccine from Pfizer last October.

  • Most active New York Stock Exchange-traded stocks Friday, 23 Jan 2015 | 1:31 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. Avon Products Inc. fell 11.0 percent to $7.71 with 19,012,600 shares traded. Bank of America Corp. fell 1.0 percent to $15.93 with 53,067,500 shares traded.

  • Midday Glance: Pharmaceuticals companies Friday, 23 Jan 2015 | 1:31 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $71.91. Bristol-Myers Squibb Co. rose$. 18 or. 3 percent, to $62.27. Hospira rose$. 50 or. 8 percent, to $65.24.

  • Early Glance: Pharmaceuticals companies Friday, 23 Jan 2015 | 11:24 AM ET

    Baxter International Inc. fell$. 22 or. 3 percent, to $72.04. Bristol-Myers Squibb Co. rose$. 12 or. 2 percent, to $62.21. Hospira rose$. 23 or. 4 percent, to $64.97.

  • Davos: Why M&A won't go away Friday, 23 Jan 2015 | 2:40 AM ET

    Activist shareholders in 2014 helped the mergers and acquisitions landscape return to the pre-crisis days of 2007 – and they'll continue to make news.

  • Final Glance: Pharmaceuticals companies Thursday, 22 Jan 2015 | 6:05 PM ET

    Baxter International Inc. rose$. 90 or 1.3 percent, to $72.26. Bristol-Myers Squibb Co. rose$. 14 or. 2 percent, to $62.09. Hospira rose$. 81 or 1.3 percent, to $64.74.

  • Jan 22- A panel of experts on Thursday voted to recommend that U.S. health regulators approve Astellas Pharma Inc's drug for the treatment of rare, often fatal invasive fungal infections that can target patients with blood cancers. The Astellas medicine, which would be sold under the proposed brand name Cresemba, was granted Orphan Drug status by the FDA, which is...

  • Midday Glance: Pharmaceuticals companies Thursday, 22 Jan 2015 | 1:29 PM ET

    Baxter International Inc. rose$. 32 or. 4 percent, to $71.68. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $62.06. Pfizer fell$. 16 or. 5 percent, to $32.48.

  • Most active New York Stock Exchange-traded stocks Thursday, 22 Jan 2015 | 1:29 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 6 percent to $33.79 with 33,768,900 shares traded. Avon Products Inc. rose 14.6 percent to $8.66 with 48,047,700 shares traded.

  • DAVOS, Switzerland, Jan 22- The GAVI global vaccines alliance is seeking to raise $7.5 billion at a funding conference in Berlin next week, as its battle to prevent infectious diseases in millions of children reaches an expected peak. The economic benefits of that will be some $80 billion and $100 billion, underscoring the cost-effectiveness of vaccines as a...

  • Early Glance: Pharmaceuticals companies Thursday, 22 Jan 2015 | 12:09 PM ET

    Baxter International Inc. fell$. 11 or. 2 percent, to $71.25. Bristol-Myers Squibb Co. fell$. 19 or. 3 percent, to $61.76. Hospira fell$. 17 or. 3 percent, to $63.76.

  • Final Glance: Pharmaceuticals companies Wednesday, 21 Jan 2015 | 6:01 PM ET

    Baxter International Inc. fell$. 45 or. 6 percent, to $71.36. Bristol-Myers Squibb Co. fell$. 50 or. 8 percent, to $61.95. Hospira rose$. 26 or. 4 percent, to $63.93.